Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1

Conditions

Uterine Cervical Dysplasia 1Melanoma 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Vision, Ocular × Clear all
NCT03850691 2024-01-17

Radiation and Combination Immunotherapy for Melanoma

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
4 enrolled 11 charts
Dermatologic

Melanoma

NCT02486471 2016-02-17

Hemostatic Procedure After Biopsy of the Cervix

Zydolab - Institute of Cytology and Immune Cytochemistry

Phase NA Completed
166 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡